e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Translational studies in chronic lung diseases: from bedside to bench
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Histopathologic and immunohistochemical characterization of antioxidants profiles in different compartments in severe COPD
B. T. Olejnicka, A. Rubaj, C. G. Lödahl, C. Andersson, M. Mori, J. Erjefalt (Trelleborg, Lund, Sweden; Lublin, Poland)
Source:
Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Session:
Translational studies in chronic lung diseases: from bedside to bench
Session type:
Poster Discussion
Number:
261
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. T. Olejnicka, A. Rubaj, C. G. Lödahl, C. Andersson, M. Mori, J. Erjefalt (Trelleborg, Lund, Sweden; Lublin, Poland). Histopathologic and immunohistochemical characterization of antioxidants profiles in different compartments in severe COPD. Eur Respir J 2013; 42: Suppl. 57, 261
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Altered expression of CuZn-SOD and thioredoxin correlate with the histopathological features in small airways of patients with severe COPD
Source: International Congress 2015 – Inflammation and remodelling in lung disease
Year: 2015
Quantitative immunohistochemical differences between catalase and thioredoxin in different anatomic compartments of the lung in severe COPD
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Morphological markers of resistance bronchial mucosa of smokers to the development of COPD
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016
Bronchial epithelial gene expression of NOX isoforms are related to important clinical characteristics in COPD
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Correlation between immunohistochemical CuZn-SOD expression and the histopathological features in small airways of patients with severe COPD
Source: Annual Congress 2012 - Inflammatory mechanisms in COPD
Year: 2012
Metabolomic signature in COPD. Plasma and lung tissue comparison identify sphingolipids as potential biomakers
Source: International Congress 2014 – Markers
Year: 2014
Assessment of endothelial dysfunction in COPD patients with different types of microcirculation disorders
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
Inflammatory phenotypes of severe exacerbation of COPD, a clinico-laboratory characterization.
Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough
Year: 2021
Alterations of the soluble proteome of airway epithelial cells in COPD
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013
Neutrophil numbers are decreased in bronchial biopsies from patients with COPD
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Molecular, metabolic and histological profiling reveal smoke worsens inflammation in a mouse model of viral COPD exacerbation
Source: Eur Respir J 2005; 26: Suppl. 49, 251s
Year: 2005
Distinct clinical and pathological phenotypes in IPF
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
Longitudinal characterization of lymphangiogenesis in lungs of patients with diffuse alveolar damage: a histopathological, immunohistochemical and mrophometric study
Source: Annual Congress 2007 - Acute and chronic lung injury and its repair: novel molecular insight
Year: 2007
A functional imaging study to investigate the relationship between pulmonary inflammation and systemic inflammation in COPD patients
Source: International Congress 2016 – From microimaging to functional evaluation of the lung
Year: 2016
Metabolomics profiling identifies female-selective upregulation of oxidative stress in individuals with COPD
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016
LATE-BREAKING ABSTRACT: Ultrastructural and functional properties of cultured lung cancer-associated myofibroblasts
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013
The expression of antioxidants in small airways in COPD is increased, heterogeneous and correlates with local histopathological alterations
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009
Serum exosomes from IPF patients display a fibrotic miRNA profile that correlates to clinical measures of disease severity
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
Molecular phenotyping of chronic bronchitis: mucin and inflammatory gene expression heterogeneity in COPD
Source: International Congress 2017 – Systemic and airway biomarkers
Year: 2017
Features of the bronchial mucosa in heavy smokers with and without chronic obstructive pulmonary disease
Source: International Congress 2015 – COPD: interesting notes
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept